Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells-Reference-Cited by-同舟云学术

Anti-Sp17 monoclonal antibody with antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activities against human ovarian cancer cells

Published:2011-12-24 Issue:4 Volume:29 Page:2923-2931
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Song Jia-xi,Cao Wang-li,Li Fang-qiu,Shi Li-ning,Jia Xuan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-011-0137-0.pdf

Reference44 articles.

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA: Cancer J Clincians. 2010;60(5):277–300.

2. Kristedja TS, Morgan RJ, Cristea M. Targeted agents in ovarian cancer. Women’s Health (London, England). 2010;6(5):679–94.

3. Polakis P. Arming antibodies for cancer therapy. Curr Opin Pharmacol. 2005;5(4):382–7.

4. O’Rand MG, Widgren EE, Fisher SJ. Characterization of the rabbit sperm membrane autoantigen, RSA, as a lectin-like zona binding protein. Dev Biol. 1988;129(1):231–40.

5. Kong M, Richardson RT, Widgren EE, O’Rand MG. Sequence and localization of the mouse sperm autoantigenic protein, Sp17. Biol Reprod. 1995;53(3):579–90.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasound-mediated immune regulation in tumor immunotherapy;Materials Today Advances;2022-06

2. Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering;Molecular Therapy - Oncolytics;2021-12

3. Spermatological parameters of immunologically sexed bull semen assessed by imaging flow cytometry, and dairy farm trial;Reproductive Biology;2021-06

4. Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth;Cancers;2021-02-05

5. Dichotomy of complement system: Tumorigenesis or destruction;Immunology Letters;2020-07